Related Experiment Videos
[Lung cancer and COPD: a common combination]
José Abal Arca1, Isaura Parente Lamelas, Raquel Almazán Ortega
1Servicio de Neumología, Complexo Hospitalario Ourense, Ourense, España. jose.abal.arca@sergas.es
Background And Objective:
To analyse frequency, characteristics and patient survival with lung cancer (LC) and COPD, comparing them with patients without COPD.
Material And Methods:
A retrospective study, of patients diagnosed by means of cytohistology. Survival was estimated by the Kaplan-Meier method. The statistical analysis was carried out using SPSS 15.0.
Results:
A total of 996 patients were diagnosed, 39.8% COPD. Mean age 70+/-9.19 years. GOLD stages: I 18.2%, II 53.6%, III 24%, IV 4.2%. The histological types: squamous cell carcinoma 48.2%, adenocarcinoma 22%, small cell carcinoma 22.5%. Survival was longer in the COPD group.
Conclusions:
LC and COPD are combined in 39.8%. Squamous cell type is more frequent and survival was longer in the COPD group.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations